Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
W Woo, ET Carey, M Choi - OncoTargets and therapy, 2019 - Taylor & Francis
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
W Woo, ET Carey, M Choi - OncoTargets and Therapy, 2019 - dovepress.com
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
W Woo, ET Carey, M Choi - OncoTargets and therapy, 2019 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
W Woo, ET Carey, M Choi - OncoTargets and Therapy, 2019 - search.proquest.com
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
[HTML][HTML] Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
W Woo, ET Carey, M Choi - OncoTargets and therapy, 2019 - ncbi.nlm.nih.gov
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives.
W Woo, ET Carey, M Choi - OncoTargets and Therapy, 2019 - go.gale.com
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives.
W Woo, ET Carey, M Choi - Oncotargets and Therapy, 2019 - europepmc.org
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives.
W Woo, ET Carey, M Choi - OncoTargets & Therapy, 2019 - search.ebscohost.com
Pancreatic cancer is a highly lethal disease, where the mortality closely matches increasing
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …
incidence. Pancreatic ductal adenocarcinoma (PDAC) is the most common histologic type …